-+ 0.00%
-+ 0.00%
-+ 0.00%

DIAMEDICA THERAPEUTICS ANNOUNCES 75% ENROLLMENT MILESTONE IN REMEDY2 PHASE 2/3 ACUTE ISCHEMIC STROKE TRIAL

Reuters·05/20/2026 12:30:00

Please log in to view news